1. Sensorineural Hearing Loss in Non-depressed Essential Tremor Cases and Controls: A Clinical and Audiometric Study.
Yilmaz NH, Akbostanci MC, Yılmaz N.
Tremor Other Hyperkinet Mov (N Y). 2015 Jan 29;5:281. doi: 10.7916/D8XW4HKQ. eCollection 2015.
2. Plasma insulin-like growth factor 1 is associated with cognitive impairment in Parkinson’s disease.
Ma J, Jiang Q, Xu J, Sun Q, Qiao Y, Chen W, Wu Y, Wang Y, Xiao Q, Liu J, Tang H, Chen S.
Dement Geriatr Cogn Disord. 2015;93(5-6):251-6. doi: 10.1159/000371510. Epub 2015 Jan 31.
3. Orthostatic tremor and parkinsonism.
Heilman KM.
Parkinsonism Relat Disord. 2015 Jan 28. pii: S1353-8020(15)00034-6. doi: 10.1016/j.parkreldis.2014.12.
4. The therapeutic potential of Berberine chloride hydrate against harmaline-induced motor impairments in a rat model of tremor.
Vaziri Z, Abbassian H, Sheibani V, Haghani M, Nazeri M, Aghaei I, Shabani M.
Neurosci Lett. 2015 Jan 30;590C:84-90. doi: 10.1016/j.neulet.2015.01.078.
5. Nonmotor symptoms in essential tremor: Comparison with Parkinson’s disease and normal control.
Lee SM, Kim M, Lee HM, Kwon KY, Koh SB.
J Neurol Sci. 2015 Feb 15;349(1-2):168-73. doi: 10.1016/j.jns.2015.01.012. Epub 2015 Jan 13.
6. Lead Exposure and Tremor among Older Men: The VA Normative Aging Study.
Ji JS, Power MC, Sparrow D, Spiro A 3rd, Howard H, Louis ED, Weisskopf MG.
Environ Health Perspect. 2015 Jan 23. [Epub ahead of print]
7. The impact of rare variants in FUS in essential tremor.
Hopfner F, Stevanin G, Müller SH, Mundwiller E, Bungeroth M, Durr A, Pendziwiat M, Anheim M, Schneider SA, Tittmann L, Klebe S, Lorenz D, Deuschl G, Brice A, Kuhlenbäumer G.
Mov Disord. 2015 Jan 28. doi: 10.1002/mds.26145.
8. Is There a Role for DAT-SPECT Imaging in a Specialty Movement Disorders Practice?
Bega D, Gonzalez-Latapi P, Zadikoff C, Spies W, Simuni T.
Neurodegener Dis. 2015 Jan 15. [Epub ahead of print]
9. Distinguishing the central drive to tremor in Parkinson’s disease and essential tremor.
Brittain JS, Cagnan H, Mehta AR, Saifee TA, Edwards MJ, Brown P.
J Neurosci. 2015 Jan 14;35(2):795-806. doi: 10.1523/JNEUROSCI.3768-14.
10. Morphometric and functional MRI changes in essential tremor with and without resting tremor.
Nicoletti V, Cecchi P, Frosini D, Pesaresi I, Fabbri S, Diciotti S, Bonuccelli U, Cosottini M, Ceravolo R.
J Neurol. 2015 Jan 9.
11. Non-invasive transcranial brain ablation with high-intensity focused ultrasound.
Jenne JW.
Front Neurol Neurosci. 2015;36:94-105. doi: 10.1159/000366241. Epub 2014 Dec 22.
12. Methamphetamine/amphetamine abuse and risk of Parkinson’s disease in Utah: a population-based assessment.
Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR.
Drug Alcohol Depend. 2015 Jan 1;146:30-8. doi: 10.1016/j.drugalcdep.2014.10.
13. Experience with DaTscan at a tertiary referral center.
Sadasivan S, Friedman JH.
Parkinsonism Relat Disord. 2015 Jan;21(1):42-5. doi: 10.1016/j.parkreldis.2014.10.
14. Frequency-dependent functional neuromodulatory effects on the motor network by ventral lateral thalamic deep brain stimulation in swine.
Paek SB, Min HK, Kim I, Knight EJ, Baek JJ, Bieber AJ, Lee KH, Chang SY.
Neuroimage. 2015 Jan 15;105:181-8. doi: 10.1016/j.neuroimage.2014.09.
15. Neurophysiologic correlates of sonication treatment in patients with essential tremor.
Chang JW, Min BK, Kim BS, Chang WS, Lee YH.
Ultrasound Med Biol. 2015 Jan;41(1):124-31. doi: 10.1016/j.ultrasmedbio.2014.
16. Different magnetic resonance imaging patterns after transcranial magnetic resonance-guided focused ultrasound of the ventral intermediate nucleus of the thalamus and anterior limb of the internal capsule in patients with essential tremor or obsessive-compulsive disorder.
Jung HH, Chang WS, Rachmilevitch I, Tlusty T, Zadicario E, Chang JW.
J Neurosurg. 2015 Jan;122(1):162-8. doi: 10.3171/2014.8.JNS132603.
17. Influence of common synaptic input to motor neurons on the neural drive to muscle in essential tremor.
Gallego JA, Dideriksen JL, Holobar A, Ibáñez J, Pons JL, Louis ED, Rocon E, Farina D.
J Neurophysiol. 2015 Jan 1;113(1):182-91. doi: 10.1152/jn.00531.2014.
Début 2026 nous vous informions que APTES rejoignait le Comité des acteurs de la société civile du cerveau (CASCC) qui aujourd’hui est renommé Comité France Cerveau.
